Biolase (BIOL) Reports In-Line Q1 EPS
Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $10 million versus the consensus estimate of $10.96 million.
For earnings history and earnings-related data on Biolase (BIOL) click here.
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share